BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37482844)

  • 21. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
    Einspahr JG; Martinez ME; Jiang R; Hsu CH; Rashid A; Bhattacharrya AK; Ahnen DJ; Jacobs ET; Houlihan PS; Webb CR; Alberts DS; Hamilton SR
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1443-50. PubMed ID: 16896030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
    Komatsu K; Andoh A; Ishiguro S; Suzuki N; Hunai H; Kobune-Fujiwara Y; Kameyama M; Miyoshi J; Akedo H; Nakamura H
    Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
    Katori H; Nozawa A; Tsukuda M
    Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Epidermal Growth Factor Receptor in Colorectal Adenocarcinoma and its Correlation with Clinicopathological Factors.
    Nemanqani DM; Aftab K; Al-Malki SH; Al-Sufyani WM
    J Coll Physicians Surg Pak; 2018 Jul; 28(7):527-531. PubMed ID: 29950257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathologic features and proliferative status of colorectal serrated lesions: a study of 104 cases].
    Wang LP; Yang GZ; Zhou ZY; Li L; Gao BL; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2009 Feb; 38(2):100-5. PubMed ID: 19573354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
    Takei K; Watanabe H; Itoi T; Saito T
    Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas.
    Herstad KMV; Gunnes G; Rørtveit R; Kolbjørnsen Ø; Tran L; Skancke E
    BMC Vet Res; 2021 Mar; 17(1):119. PubMed ID: 33712002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
    Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases.
    Karameris A; Kanavaros P; Aninos D; Gorgoulis V; Mikou G; Rokas T; Niotis M; Kalogeropoulos N
    Pathol Res Pract; 1993 Mar; 189(2):133-7. PubMed ID: 8321742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67.
    Shin IY; Sung NY; Lee YS; Kwon TS; Si Y; Lee YS; Oh ST; Lee IK
    Gut Liver; 2014 Jan; 8(1):13-23. PubMed ID: 24516696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of cancer clones in human colorectal adenoma as revealed by increased DNA instability and other bio-markers.
    Jin Y; Sun A; Noriki S; Imamura Y; Fukuda M
    Eur J Histochem; 2007; 51(1):1-10. PubMed ID: 17548263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Vascular Endothelial Growth Factor (VEGF) in Colorectal Adenoma and Carcinoma in a Tertiary Care Center.
    Balasubramanian S; Priyathersini N; Johnson T
    Cureus; 2022 Nov; 14(11):e31393. PubMed ID: 36514651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
    Kavanagh DO; Chambers G; O'Grady L; Barry KM; Waldron RP; Bennani F; Eustace PW; Tobbia I
    BMC Cancer; 2009 Jan; 9():1. PubMed ID: 19118499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.
    Lakis S; Papamitsou T; Panagiotopoulou C; Kotakidou R; Kotoula V
    World J Gastroenterol; 2010 May; 16(20):2476-83. PubMed ID: 20503447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.